These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10683490)

  • 1. Circadian rhythm-dependent development of melatonin effects and tolerance to PHNO in rats.
    Munro JD; Martin-Iverson MT
    Pharmacol Biochem Behav; 2000 Mar; 65(3):495-501. PubMed ID: 10683490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pinealectomy blocks stress-induced motor stimulation but not sensitization and tolerance to a dopamine D2 receptor agonist.
    Ruzich M; Martin-Iverson MT
    Psychopharmacology (Berl); 2000 Oct; 152(3):275-82. PubMed ID: 11105937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term motor stimulant effects of (+)-4-propyl-9-hydroxynaphthoxazine (PHNO), a dopamine D-2 receptor agonist: interactions with a dopamine D-1 receptor antagonist and agonist.
    Martin-Iverson MT; Iversen SD; Stahl SM
    Eur J Pharmacol; 1988 Apr; 149(1-2):25-31. PubMed ID: 2899515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic administration of a selective dopamine D-2 agonist: factors determining behavioral tolerance and sensitization.
    Martin-Iverson MT; Stahl SM; Iversen SD
    Psychopharmacology (Berl); 1988; 95(4):534-9. PubMed ID: 2905503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic behavioural effects of dopamine D1 and D2 receptor agonists are determined by circadian rhythms.
    Martin-Iverson MT; Yamada N
    Eur J Pharmacol; 1992 Apr; 215(1):119-25. PubMed ID: 1355440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does locomotor response to novelty in rats predict susceptibility to develop sensitization to cocaine and PHNO?
    Djano S; Martin-Iverson MT
    Behav Pharmacol; 2000 Sep; 11(6):455-70. PubMed ID: 11103912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ageing on the behavioural responses to dopamine agonists: decreased yawning and locomotion, but increased stereotypy.
    Stoessl AJ; Martin-Iverson MT; Barth TM; Dourish CT; Iversen SD
    Brain Res; 1989 Aug; 495(1):20-30. PubMed ID: 2570627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective dopamine D1 and D2 agonists independently affect different components of the free-running circadian rhythm of locomotor activity in rats.
    Yamada N; Martin-Iverson MT
    Brain Res; 1991 Jan; 538(2):310-2. PubMed ID: 1826460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of intracerebroventricular infusion of (+)-4-propyl-9-hydroxynapthoxacine (PHNO) through a totally implanted drug delivery system in rats with dopamine deficiency.
    de Yebenes JG; Fahn S; Jackson-Lewis V; Mena MA
    Mov Disord; 1987; 2(4):291-9. PubMed ID: 2904650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
    Garrett BE; Holtzman SG
    Eur J Pharmacol; 1994 Sep; 262(1-2):65-75. PubMed ID: 7813580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered behavioral response to dopamine D3 receptor agonists 7-OH-DPAT and PD 128907 following repetitive amphetamine administration.
    Richtand NM; Welge JA; Levant B; Logue AD; Hayes S; Pritchard LM; Geracioti TD; Coolen LM; Berger SP
    Neuropsychopharmacology; 2003 Aug; 28(8):1422-32. PubMed ID: 12700693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.
    McCormick PN; Kapur S; Seeman P; Wilson AA
    Nucl Med Biol; 2008 Jan; 35(1):11-7. PubMed ID: 18158938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
    Galineau L; Wilson AA; Garcia A; Houle S; Kapur S; Ginovart N
    Synapse; 2006 Aug; 60(2):172-83. PubMed ID: 16715499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogeny of the motor inhibitory role of dopamine D(3) receptor subtype in rats.
    Heijtz RD; Ogren SO; Fuxe K
    Eur J Pharmacol; 2000 Mar; 392(1-2):35-9. PubMed ID: 10748270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
    Cauli O; Morelli M
    Psychopharmacology (Berl); 2002 Jul; 162(3):246-54. PubMed ID: 12122482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Yates TM
    Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
    Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian-dependent effect of melatonin on dopaminergic D2 antagonist-induced hypokinesia and agonist-induced stereotypies in rats.
    Sumaya IC; Byers DM; Irwin LN; Del Val S; Moss DE
    Pharmacol Biochem Behav; 2004 Aug; 78(4):727-33. PubMed ID: 15301928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic restoration of suppressed temperature rhythms in rats by melatonin, melatonin receptor agonist, S20242, or 8-OH-DPAT.
    Deprés-Brummer P; Metzger G; Lévi F
    Eur J Pharmacol; 1998 Apr; 347(1):57-66. PubMed ID: 9650848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An endogenous dopaminergic tone acting on dopamine D3 receptors may be involved in diurnal changes of tuberoinfundibular dopaminergic neuron activity and prolactin secretion in estrogen-primed ovariectomized rats.
    Liang SL; Pan JT
    Brain Res Bull; 2012 Feb; 87(2-3):334-9. PubMed ID: 22155687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.